News-Medical.net |
Bluebird, Celgene Myeloma Therapy Appears to Improve in Time
Bloomberg A novel therapy from Bluebird Bio Inc. and Celgene Corp. for patients nearing death from an aggressive form of blood cancer appears to get more effective over time, wiping out signs of disease in more than half of those treated in a small trial. A ... CAR T, immunotherapy bring new hope for multiple myeloma patients 'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study Two immunotherapy approaches for multiple myeloma show hope |
from Health - Google News http://ift.tt/2iXVd2d
EmoticonEmoticon